Effect of Creatine Supplementation Dosing Strategies on Aging Muscle Performance.


Journal

The journal of nutrition, health & aging
ISSN: 1760-4788
Titre abrégé: J Nutr Health Aging
Pays: France
ID NLM: 100893366

Informations de publication

Date de publication:
2019
Historique:
entrez: 2 3 2019
pubmed: 2 3 2019
medline: 11 6 2020
Statut: ppublish

Résumé

This study compared the effects of different creatine supplementation dosages, independent of resistance training, on aging muscle performance and functionality. Using a double-blind, repeated measures design, participants were randomized to one of three groups: Creatine-High (CR-H; n=11; 0.3 g/kg/day of creatine + 0.1 g/kg/day of maltodextrin), Creatine-Moderate (CR-M: n=11; 0.1 g/kg/day of creatine + 0.3 g/kg/day of maltodextrin) or Placebo (PLA; n=11; 0.4 g/kg/day of maltodextrin) for 10 consecutive days. The primary dependent variables measured at baseline and after supplementation included muscle strength (1-repetition maximum leg press, chest press, hand-grip), muscle endurance (leg press and chest press; maximal number of repetitions performed for 1 set at 80% and 70% baseline 1-repetition maximum respectively), and physical performance (dynamic balance). There was a significant increase over time for muscle strength (Leg press: CR-H pre 161.5 ± 55.1 kg, post 169.2 ± 59.2 kg; CR-M pre 145.2 ± 47.7 kg, post 151.7 ± 45.0 kg; PLA pre 163.7 ± 51.5 kg, post 178.2 ± 65.6 kg, p = 0.001; Chest press: CR-H pre 57.0 ± 26.2 kg, post 58.8 ± 28.0 kg; CR-M pre 54.5 ± 27.9 kg, post 56.8 ± 30.1 kg; PLA pre 55.1 ± 26.9 kg, post 58.5 ± 30.1 kg, p = 0.001) and endurance (Leg press: CR-H pre 17.1 ± 6.0 reps, post 21.0 ± 7.2 reps; CR-M pre 24.1 ± 11.6 reps, post 29.1 ± 17.0 reps; PLA pre 23.8 ± 9.7 reps, post 29.5 ± 11.9 reps, p = 0. 001; Chest press: CR-H pre 15.6 ± 2.7 reps, post 18.9 ± 2.7 reps; CR-M pre 18.0 ± 5.0 reps, post 19.9 ± 7.1 reps; PLA pre 20.5 ± 6.2 reps, post 21.6 ± 5.5 reps, p = 0. 001), with no other differences. Short-term creatine supplementation, independent of dosage and resistance training, has no effect on aging muscle performance.

Identifiants

pubmed: 30820517
doi: 10.1007/s12603-018-1148-8
doi:

Substances chimiques

Creatine MU72812GK0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

281-285

Déclaration de conflit d'intérêts

The authors report no conflict of interest

Références

Eur J Appl Physiol Occup Physiol. 1999 Jul;80(2):139-44
pubmed: 10408325
Physiol Rev. 2000 Jul;80(3):1107-213
pubmed: 10893433
J Sci Med Sport. 2000 Sep;3(3):287-98
pubmed: 11101268
J Appl Physiol (1985). 2001 Sep;91(3):1041-7
pubmed: 11509496
Am J Physiol Endocrinol Metab. 2002 Mar;282(3):E551-6
pubmed: 11832356
Can J Appl Physiol. 2001 Dec;26(6):588-606
pubmed: 11842275
Med Sci Sports Exerc. 2002 Mar;34(3):537-43
pubmed: 11880821
Int J Sport Nutr Exerc Metab. 2001 Dec;11 Suppl:S119-27
pubmed: 11915910
Int J Sport Nutr Exerc Metab. 2001 Dec;11 Suppl:S28-43
pubmed: 11915925
J Strength Cond Res. 2004 Aug;18(3):610-7
pubmed: 15320650
Sports Med. 2004;34(12):809-24
pubmed: 15462613
Clin Sci (Lond). 1991 Aug;81(2):249-56
pubmed: 1716189
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Eur J Appl Physiol. 2008 Jan;102(2):223-31
pubmed: 17943308
J Nutr Health Aging. 2007 Nov-Dec;11(6):459-64
pubmed: 17985060
Appl Physiol Nutr Metab. 2008 Feb;33(1):184-90
pubmed: 18347671
Int J Sport Nutr Exerc Metab. 2008 Oct;18(5):493-508
pubmed: 19033611
Med Sci Sports Exerc. 2010 Jul;42(7):1286-95
pubmed: 20019638
Dyn Med. 2009 Dec 24;8:6
pubmed: 20034396
Ageing Res Rev. 2010 Oct;9(4):369-83
pubmed: 20438881
J Bone Miner Res. 2013 Apr;28(4):780-93
pubmed: 23165609
Endocrine. 2014 Apr;45(3):354-61
pubmed: 24190049
Res Sports Med. 2014;22(1):61-74
pubmed: 24392772
Med Sci Sports Exerc. 2014 Jun;46(6):1194-203
pubmed: 24576864
Appl Physiol Nutr Metab. 2015 Jul;40(7):689-94
pubmed: 25993883
Exp Gerontol. 2015 Oct;70:97-104
pubmed: 26192975
J Strength Cond Res. 2016 Jun;30(6):1763-6
pubmed: 26562708
Amino Acids. 2016 Aug;48(8):1793-805
pubmed: 27108136
Exp Gerontol. 2016 Oct;83:112-9
pubmed: 27523919
J Int Soc Sports Nutr. 2017 Jun 13;14:18
pubmed: 28615996
Open Access J Sports Med. 2017 Nov 02;8:213-226
pubmed: 29138605
Can J Appl Sport Sci. 1985 Sep;10(3):141-6
pubmed: 4053261
Exp Physiol. 1998 Jan;83(1):107-17
pubmed: 9483424

Auteurs

J Chami (J)

Darren G. Candow, PhD, Professor and Associate Dean-Graduate Studies and Research, Faculty of Kinesiology and Health Studies, 3737 Wascana Parkway, University of Regina, Regina SK Canada, S4S 0A2, KHS.GSR-AssocDean@uregina.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH